Evidence map›Paper›PMID 31572393›Full record

ReviewFrontiers in immunology2019

The Rise of

Marley C Caballero Van Dyke, George R Thompson, John N Galgiani, Bridget M Barker

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.

  1. The microbiome of bat guano: for what is this knowledge important?Applied microbiology and biotechnology · 2021
    Pooled it
  2. Article
  3. Article
  4. Review
  5. Computational Approaches for Discovering Virulence Factors inJournal of fungi (Basel, Switzerland) · 2025
    Review
  6. Article
  7. Article
  8. OptimizingmSphere · 2025
    Article
  9. Article
  10. From soil to clinic: current advances in understandingMicrobiology and molecular biology reviews : MMBR · 2024
    Review
  11. Article
  12. Article
  13. Review
  14. Journal of fungi (Basel, Switzerland) · 2024
    Article
  15. Article
  16. Article
  17. Neurosarcoidosis, Coccidioidomycosis, or Both!International medical case reports journal · 2023
    Article
  18. Molecular Diagnosis of Endemic Mycoses.Journal of fungi (Basel, Switzerland) · 2022
    Review
  19. Article
  20. Invasive Fungal Diseases in Africa: A Critical Literature Review.Journal of fungi (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Marley C Caballero Van DykePathogen and Microbiome Institute, Northern Arizona University, Flagstaff, AZ, United States.
George R ThompsonDepartment of Medical Microbiology and Immunology, University of California, Davis, Davis, CA, United States.
John N GalgianiValley Fever Center for Excellence, Department of Medicine, University of Arizona College of Medicine-Tucson, Tucson, AZ, United States.
Bridget M BarkerPathogen and Microbiome Institute, Northern Arizona University, Flagstaff, AZ, United States.
Northern Arizona University · USUniversity of Arizona · USUniversity of California Davis Medical Center · US

Funding

An Avirulent Arthroconidial Vaccine Candidate to Prevent Human CoccidioidomycosisR01AI132140 · NIAID · UNIVERSITY OF ARIZONA · PI GALGIANI, JOHN N · 2017 to 2020
$4.8M
Immuno-Genetic Basis for Human Disseminated CoccidioidomycosisU01AI122275 · NIAID · UNIVERSITY OF ARIZONA · PI GALGIANI, JOHN N, HOLLAND, STEVEN M · 2017 to 2020
$2.3M
Defining the Mechanisms of Recombination in CoccidioidesR21AI128536 · NIAID · NORTHERN ARIZONA UNIVERSITY · PI BARKER, BRIDGET MARIE · 2018 to 2019
$408k
NIAID NIH HHS R01 AI132140NIAID NIH HHS R21 AI128536NIAID NIH HHS U01 AI122275
6 · The paper itself

Abstract

Coccidioidomycosis (Valley fever) is a fungal disease caused by the inhalation of

Indexed as

CoccidioidomycosisDustArizonaCaliforniaCoccidioidesFungal VaccinesHumansDustFungal Vaccinesantifungal drugsCoccidioidesfungal vaccinesimmunityvalley fever

Identifiers

PMID31572393
PMCPMC6749157
OpenAlexW2970817563

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.